2026 Annual Summit Calls for Accelerating Patient Access to Healthcare Innovation

The Central American and Caribbean Federation of Pharmaceutical Laboratories (Fedefarma) convened the inaugural 2026 Annual Summit, bringing together health authorities, regulators, academics, patient organizations, medical societies, and pharmaceutical innovators to address the growing gap between medical innovation and patient access. The summit focused on identifying strategies to bridge the divide that prevents patients from benefiting from new treatments and medications. By fostering dialogue among stakeholders across the healthcare ecosystem, the conference aims to streamline pathways for bringing innovative therapies to patients throughout the region. For Puerto Rico and Caribbean patients, accelerating access to healthcare innovation means faster availability of advanced treatments for chronic and complex conditions.